PurposeThere is interest in using dual-energy computed tomography (DECT) to evaluate organ function before and after radiotherapy. The purpose of this study (trial identifier: XXXX) is to assess longitudinal changes in lung perfusion using iodine maps derived from DECT in lung cancer patients treated with conventional or stereotactic radiotherapy (RT). MethodsFor 48 prospectively enrolled lung cancer patients, a contrast-enhanced DECT using a dual-source CT simulator was acquired pre-treatment and at 6 and 12 months post-treatment. Pulmonary functions tests (PFT) were obtained at baseline and at 6 and 12 months post-treatment. Iodine maps were extracted from the DECT images using a previously described 2-material decomposition framework. Longitudinal iodine maps were normalized using a reference region defined as all voxels with perfusion in the top 10% outside of the 5 Gy isodose volume. Normalized functional responses (NFR) were calculated for three dose ranges: <5 Gy, 5-20 Gy and >20 Gy. Mixed model analysis was used to assess the correlation between dose metrics and NFR. Pearson correlation was used to assess if NFR are correlated with PFT changes. ResultsOut of the 48 patients, 21 (44%) were treated with stereotactic body radiation therapy (SBRT) and 27 (56%) were treated with conventionally fractionated IMRT. 31 out of these 48 patients were ultimately included in data analysis. It was found that NFR is linearly correlated with dose (p < 0.001) for both groups. The number of months elapsed post-RT is also found to correlate with NFR (p = 0.029), although this correlation was not observed for the SBRT subgroup. The NFR is not found to correlate with PFT changes. ConclusionDECT derived iodine maps are a promising method for detailed anatomic evaluation of radiation effect on lung function, including potentially subclinical changes.